TIDMCLL

RNS Number : 5348V

Cello Health PLC

07 August 2020

7 August 2020

Cello Health plc

("Cello" or the "Company")

Additional Block Listing of Ordinary Shares

Following the Court Hearing held earlier today in connection with the cash acquisition of Cello Health plc by Pharma Value Demonstration Bidco Limited, the Company announces that an application has been made for a block admission for 2,421,000 new ordinary shares of 10p each ("Ordinary Shares") to be admitted to trading on AIM.

These new Ordinary Shares will be issued and allotted pursuant to the exercise of existing options under the Company's Performance Share Plan 2010, the HM Revenue & Customs Approved Company Share Option Plan and its Unapproved Share Option Plan. New Ordinary Shares, when issued, will rank pari passu with the existing Ordinary Shares of the Company.

Admission of the new Ordinary Shares is expected to occur on 10 August 2020.

Enquires

 
 Cello Health                   020 7812 8460 
 Mark Scott, Chief Executive 
 Mark Bentley, Group Finance 
  Director 
 
 Cenkos Securities              020 7397 8900 
 Giles Balleny 
 Harry Hargreaves 
 
 Buchanan                       020 7466 5000 
 Mark Court 
 Jamie Hooper 
 Sophie Wills

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ALSEAFPXELNEEFA

(END) Dow Jones Newswires

August 07, 2020 07:52 ET (11:52 GMT)

Cello Health (LSE:CLL)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Cello Health Charts.
Cello Health (LSE:CLL)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Cello Health Charts.